Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emami Ltd Annual Report 2020

Jun 26, 2020

61637_rns_2020-06-26_6b175f23-de4e-409c-be52-574ec321f253.pdf

Annual Report

Open in viewer

Opens in your device viewer

Q4 & FY20 Performance Update

26th June 2020

FY20 Performance Snapshot (Consolidated)

Key Financials FY20 Growth Q4FY20
Growth
9MFY20
Growth*
Consolidated Revenue Growth -1% -17% 3%
Domestic
Business Growth
(incl. Institutional)
-4% -19% 0%
International Business growth 16% -4% 24%
EBIDTA Growth -5% -37% 4%
PAT Growth 0% -58% 13%
Cash
Profit Growth
2% -21% 8%

*Limited Review

  • Weak rural demand and liquidity concerns persisted prior to lockdown and supply chain disrupted from mid-March due to COVID-19
  • Operations came to a complete halt during the last week of March due to nation wide lockdown affecting the pre-season sale of the summer portfolio impacting Q4 & FY20 performance

Business Performance

Key Market Shares

Key Brands Market Share
Volume*
Growth over
PY
Navratna
Oils
66.4% + 10 bps
Zandu
+ Mentho
Plus Balms
54.9% + 130bps
BoroPlus
Antiseptic
Cream
74.1% + 30bps
Fair and
Handsome Cream
65.3% -
30
bps
Kesh
King Oil
26.6% + 140 bps

Domestic Brandwise performance

Key Brands FY20 Growth Q4FY20
Growth
9MFY20
Growth
Navratna
Range
-2% -12% 4%
Pain Management Range 3% -5% 5%
BoroPlus
Range
-7% -77% 0%
Kesh
King
Range
1% -26% 12%
Healthcare Range -2% -9% 1%
Male Grooming Range -29% -42% -25%
7 Oils in One 29% 5% 39%

Foray into Hygiene space

BoroPlus Advanced Anti-Germ Hand Sanitizer

Launched in April'20

BoroPlus Antiseptic+ Moisturizing Soap

Launched in June'20

BoroPlus Antiseptic+ Moisturizing Handwash

To be launched in June'20

New Launches in Healthcare Range

Zandu Ayurvedic Hand Sanitizer

Zandu Ayush Kwath Powder

Launched in June'20

An Ayurvedic immunity booster Kadha launched in June'20

Zandu Single Herb Range

  • Amalaki: Guaranteed immunity builder
  • Asvagandha: Immunity Booster / Adaptogenic stress buster
  • Giloy: Immunity booster / promotes liver function
  • Neem: Immunity booster / protects from skin infections
  • Tulasi: Immunity booster for family
  • Turmeric: Immunity Booster / Protects from infections

New Launches/ Relaunches in Q4FY20

Navratna Smart Cool Talc relaunched as "Maxx Cool" for Longest Lasting Cooling

Relaunched Navratna Cool Talc with modernized packaging and superior claims

Launched BoroPlus Organic Aloevera Gel - The only gel with 100% organic Aloe Leaf Extract, Antiseptic Herbs & Vitamin E for Healthy, Hydrated and Nourished Skin and Hair

New Media campaigns

8

Roped in Bollywood superstar Salman Khan as Raahat Raja, the popular icon of Navratna.

The commercial has been directed by Nitesh Tiwari (Dangal and Chhichhore fame)

Expected to extend the product messaging to the masses

Digital Campaign for Zandu Immunity Building range

Aired Medifacts Campaign to build superiority of Zandu Balms against painkiller tablets

International Business

  • Sales grew by 16% in FY20. However, sales declined by 4% in Q4
  • SAARC, MENAP and CIS grew in double digits in FY20
  • Market shares across key markets continued to grow consistently –
  • Bangladesh (Navratna, Fair and Handsome and 7 Oils in One)
  • UAE (Navratna and Fair and Handsome)
  • Russia (BoroPlus)

  • SAARC South Asian Association for Regional Cooperation (Major countries – Bangladesh, Nepal, Sri Lanka etc.)
  • SEA South East Asia (Major countries – Malaysia, Myanmar & Singapore)
  • MENAP Middle East, North Africa & Pakistan (Major countries – UAE, Qatar, Oman, Kuwait, Bahrain etc.)
  • CIS Commonwealth of Independent States (Major Countries – Russia, Ukraine etc.)

Financial Analysis

Earnings analysis for Q4 & FY20

Q4FY20 Financial analysis

FY20 Financial analysis

12

Q4FY20 Summarized Financials

₹ in Millions

Particulars Q4FY20 % Q4FY19 % Growth %
Net Sales 5,228.3 98.2% 6,350.3 99.2% -17.7%
Other Operating Income 98.5 1.8% 53.2 0.8% 85.2%
Revenue from Operations 5,326.8 100.0% 6,403.5 100.0% -16.8%
Materials Cost 1,856.0 34.8% 2,507.7 39.2% -26.0%
A&P 989.1 18.6% 989.8 15.5% -0.1%
Staff Cost 720.6 13.5% 680.9 10.6% 5.8%
Admn & Other Exp 775.8 14.6% 670.9 10.5% 15.6%
EBIDTA 985.3 18.5% 1,554.2 24.3% -36.6%
Other Income 144.9 2.7% 165.6 2.6% -12.5%
Interest 24.1 0.5% 62.1 1.0% -61.2%
Amortisation of acquired TM's/ brands 633.0 11.9% 650.3 10.2% -2.7%
Depreciation/Amortisation of other assets 219.4 4.1% 159.7 2.5% 37.4%
PBT before Exceptional Items 253.7 4.8% 847.7 13.2% -70.1%
Exceptional Items 74.2 1.4% - 0.0% 100.0%
PBT 179.5 3.4% 847.7 13.2% -78.8%
Tax (73.7) -1.4% 279.8 4.4% -126.3%
PAT 253.2 4.8% 567.9 8.9% -55.4%
Share of Minority Interest & P/L of Associate (19.6) -0.4% (6.4) -0.1% 206.2%
PAT After Minority Interest & Associate 233.6 4.4% 561.5 8.8% -58.4%
Cash Profit (PAT + Dep. & Amortization) 1,086.0 20.4% 1,371.5 21.4% -20.8%
EPS -
Rs.
0.51 1.24
Cash EPS-
Rs.
2.39 3.02

FY20 Summarized Financials

₹ in Millions

Particulars FY20 % FY19 % Growth %
Net Sales 26,106.4 98.3% 26,589.2 98.7% -1.8%
Other Operating Income 442.4 1.7% 357.1 1.3% 23.9%
Revenue from Operations 26,548.8 100.0% 26,946.3 100.0% -1.5%
Materials Cost 8,761.0 33.0% 9,230.1 34.3% -5.1%
A&P 4,711.4 17.7% 4,701.8 17.4% 0.2%
Staff Cost 2,995.1 11.3% 2,797.2 10.4% 7.1%
Admn & Other Exp 3,175.9 12.0% 2,945.0 10.9% 7.8%
EBIDTA 6,905.4 26.0% 7,272.2 27.0% -5.0%
Other Income 570.7 2.1% 349.0 1.3% 63.5%
Interest 210.1 0.8% 214.0 0.8% -1.8%
Amortisation of acquired TM's/ brands 2,589.0 9.8% 2,485.0 9.2% 4.2%
Depreciation/Amortisation of other assets 774.3 2.9% 768.2 2.9% 0.8%
PBT before Exceptional Items 3,902.7 14.7% 4,154.0 15.4% -6.0%
Exceptional Items 106.8 0.4% 98.0 0.4% 9.0%
PBT 3,795.9 14.3% 4,056.0 15.1% -6.4%
Tax 712.7 2.7% 1,008.8 3.7% -29.4%
PAT 3,083.2 11.6% 3,047.2 11.3% 1.2%
Share of Minority Interest & P/L of Associate (54.1) -0.2% (14.9) -0.1% 263.1%
PAT After Minority Interest & Associate 3,029.1 11.4% 3,032.3 11.3% -0.1%
Cash Profit (PAT + Dep. & Amortization) 6,392.4 24.1% 6,285.5 23.3% 1.7%
EPS -
Rs.
6.67 6.68
Cash EPS-
Rs.
14.08 13.85

Balance Sheet

₹ in Millions

Sl. ASSETS As at
31.03.2020
As at
31.03.2019
Sl. EQUITY AND LIABILITIES As at
31.03.2020
As at
31.03.2019
1 Non -Current Assets Equity
(a) Property, Plant and Equipment 7,685 7,490 (a) Equity Share capital 453 454
(b) Capital work-in-progress 69 352 (b) Other Equity 17,784 20,307
(c) Investment Property 545 548 Total Equity attributable to owners of the Parent 18,238 20,761
(d) Goodwill - 41 (c) Non-Controlling Interest (9) (2)
(e) Other Intangible Assets 6,191 8,722 Total Equity 18,229 20,759
(f) Right of Use Assets 172 -
(g) Intangible assets under development 12 11
(h) Financial Assets
(i) Investments LIABILITIES
a) Investment in Associates 212 160 1 Non-Current Liabilities
b) Others 669 1,631 (a) Financial Liabilities
(ii) Loans 117 143 (i) Other Financial Liabilities 154 69
(iii) Other Financial Assets 394 291
(i) Deferred Tax Assets (net) 0 38
(j) Non-Current Tax Assets 135 126 (b) Provisions 231 200
(k) Other Non-Current Assets 253 178 (c) Deferred tax liabilities (Net) 35 160
(d) Other Non-Current Liabilities 216 237
16,452 19,730 636 666
2 Current assets
(a) Inventories 2,447 2,217 2 Current liabilities
(b) Financial Assets (a) Financial Liabilities
(i) Investments 683 79 (i) Borrowings 2,102 1,099
(ii) Trade Receivables 3,080 2,164 (ii) Trade Payables
Total oustanding dues of Micro & Small
(iii) Cash & Cash Equivalents 108 1,165 enterprise 230 30
Total oustanding dues of creditors others than
(iv) Bank Balances other than (iii) above 1,082 869 Micro & Small Enterprises 3,014 2,883
(v) Loans 663 29 (iii) Other Financial Liabilities 520 1,326
(vi) Other Financial Assets 785 498 (b) Other Current Liabilities 486 245
(c) Provisions 1,455 1,153
(c) Other Current Assets 1,484
10,333
1,473
8,493
(d) Current Tax Liabilities (Net) 112
7,920
63
6,800
Total Assets 26,785 28,224 Total Equity and Liabilities 26,785 28,224

Awards & Accolades

  • Awarded the "Company of the year– FMCG" by CNBC-Awaaz for the company's outstanding performance on parameters such as growth, capital efficiency and profitability over a period of time
  • Zandu Balm, BoroPlus and Navartna bagged 35th, 75th and 96th positions among the " Top 100 Most Trusted Brands" under the aegis of The Economic Times - Brand Equity
  • HE Magic Duo and Emami 7 Oils in One were conferred with the 'Recognition of Product Packaging" under the Innovation, Creativity and Development Category. Also received the "President's Special Award" for the new and fresh packaging concept of Emami 7 Oils in One out of the Top 3 Shortlisted Packaging among all entries from SIES Educational group.

Thank you